Jayson Rieger - 06 Nov 2024 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Signature
/s/ Christopher Hayes, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
06 Nov 2024
Net transactions value
$0
Form type
4
Filing time
06 Nov 2024, 21:02:43 UTC
Previous filing
06 Nov 2024
Next filing
26 Nov 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRCA Employee Stock Option (right to buy) Award $0 +2,000,000 $0.000000 2,000,000 06 Nov 2024 Common Stock 2,000,000 $0.7463 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/8th of the total shares subject to the option shall vest on May 5, 2025, and 1/48th of the total shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continuous service through such vesting date.